. Author manuscript; available in PMC: 2010 Nov 1.

Published in final edited form as: Exp Hematol. 2009 Aug 28;37(11):1295–1309. doi: 10.1016/j.exphem.2009.08.005

Table I. Primary NHL Immunophenotypes.

Immunophenotype of representative patient samples. The Strong Memorial Hospital Pathology Laboratory performed flow cytometric and immunohistochemical analyses of patient tumor samples.

Patient Specimens	Immunophenotype data summary
06TLN0023	CD19+, CD20+, CD5+, CD10-, CD23+, FMC7-, Clonal kappa+
06TLN0046	CD19+, CD20+, CD45+, CD10+, CD23+, FMC7-, CD3-, BCL2+, Clonal lambda+
06TLN0031	CD19+, CD20+, CD5-, CD22+, CD10+, CD23+, CD79+, FMC7+, CD38-, CD3-, BCL6+, Clonal kappa+
06TLN0090	CD19+, CD20+, CD5-, CD10+, CD23+, CD3-, CD79a+, BCL2+, BCL6+, Clonal lambda+
07TLN0154	Data unavailable
07TLN0128	CD19+, CD20+, CD10+, CD79a+, FMC7+, BCL2+, BCL6+, Clonal lambda+
07TLN0103	CD19+, CD20+, CD5+, CD10+, CD45+, Clonal kappa+
06TPL0027	CD19+, CD20+, CD5-, CD10+, CD22+, CD23-, FMC7-, Clonal kappa+
07TXN0131	CD19+, CD20+, CD10-, CD45+, CD79a+, BCL2-, BCL6-, Light chains-